中文 | English
Return
Total: 245 , 1/25
Show Home Prev Next End page: GO
Author:(Shao-rong CHEN)

1.Review of biosimilar regulatory guidelines and scientific principles:Experiences from Europe-an Medicines Agency (EMA) guidelines

Ming CHEN ; Rong SHAO

Chinese Journal of Health Policy 2014;(10):21-26

2.Enlightenment of ADR Victims' Relief System of Japan

Yongfa CHEN ; Rong SHAO

China Pharmacy 2001;0(10):-

3.Research of Constructing and Improving National Essential Drug Policy

Yongfa CHEN ; Rong SHAO

China Pharmacy 1991;0(02):-

4.Effect of the "Tragedy of Anti-commons" on Biomedical Research & Development

Xin CHEN ; Rong SHAO

China Pharmacy 1991;0(05):-

5.Revelation of the second-generation national health care reform in Taiwan area on the equity and sustainability of the medicare fund in mainland China

Zhiyuan CHEN ; Rong JIANG ; Rong SHAO

Chinese Journal of Health Policy 2017;10(2):50-56

7.Analysis on Prevention of Authority Dissimilation of Drug Registration with Economic Models

Ying JIANG ; Yongfa CHEN ; Rong SHAO

China Pharmacy 2005;0(21):-

8.Relationship between Characteristic of Pathohistology and Helicobater Pylori in Chronic Gastritis

cai-hong, SHAO ; qi-rong, ZHU ; lian, CHEN

Journal of Applied Clinical Pediatrics 2004;0(09):-

9.Improvement of dysphagia in patients with esophagus stenosis following carcinoma of esophagus

Ming LI ; Shao guang GAN ; Shizhou HUAN ; Rong fan CHEN ;

Chinese Journal of Tissue Engineering Research 2002;6(2):302-

10.Overview on the New Dosage Forms of Sirolimus

Mingjie PAN ; Rong DU ; Ying CHEN ; Ge SHAO

China Pharmacist 2016;19(6):1183-1186

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 245 , 1/25 Show Home Prev Next End page: GO